Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ferrous sulfate** is an inorganic ferrous iron salt used primarily as oral iron-replacement therapy for the prevention and treatment of iron deficiency and iron deficiency anemia. It dissociates in the gastrointestinal tract to provide absorbable ferrous iron, replenishing iron available for hemoglobin synthesis, erythropoiesis, and restoration of body iron stores. Oral absorption can be reduced by inflammation-associated hepcidin elevation, including in active inflammatory bowel disease and some patients with chronic kidney disease. It is available in multiple immediate-release oral presentations, including tablets and liquid products. ([dailymed.awsprod.nlm.nih.gov](https://dailymed.awsprod.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9fb466fe-9c2b-4014-9913-029348bda14c))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous sulfate.